Modern diagnostic technologies are one of the fastest growing trends in medicine. Medisensonic consistently follows its vision of innovative and safe medicine of the future, aiming to become a leader in the field of non-invasive diagnostics. Become our partner and invest in the future!

Shareholder Structure

27,78%
Zenon Szczepaniak
960 shares
24,88%
Robert Gromada
860 shares
13,89%
Andrzej Trznadel
480 shares
2,89%
Sylwia Gromada
100 shares
30,56%
other Shareholders
1 056 shares
27,78%
Zenon Szczepaniak
960 votes
24,88%
Robert Gromada
860 votes
13,89%
Andrzej Trznadel
480 votes
2,89%
Sylwia Gromada
100 votes
30,56%
other Shareholders
1 056 votes

Table of Shares and Votes

Shareholders
Number of shares
Number of votes
% shares
% votes
Zenon Szczepaniak
960
960
27,78%
27,78%
Robert Gromada
860
860
24,88%
24,88%
Andrzej Trznadel
480
480
13,89%
13,89%
Sylwia Gromada
100
100
2,89%
2,89%
other Shareholders
1 056
1 056
30,56%
30,56%

General Meeting

Minutes of the Extraordinary General Meeting

October 15 2021
read more
read more
General Meeting

Corporate Governance

09/09/2021

Memorandum of association

21/01/2022

Registration of capital in a National Court Register

Contact for Investors

Andrzej Trznadel
Board Representative for Investor Relations
inwestor@medisensonic.com
Robert Gromada
CEO
inwestor@medisensonic.com
Action Planner
Navigator Capital Advisory Sp. z o.o.
Twarda Street 18, 00-105 Warsaw, Poland
www.navigatorcapital.pl
biuro@navigatorcapital.pl
Address for notifications
In accordance with Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR).
mar@medisensonic.com
Nasza strona wykorzystuje pliki cookies, aby zapewnić najlepszą jakość przeglądania w witrynie oraz do celów statystycznych. Pliki cookie możesz wyłączyć w swojej przeglądarce internetowej. Więcej informacji znajdziesz w naszej Polityce prywatności.
akceptuję